The Canadian Gastro-Intestinal Epidemiology Consortium invited IBD epidemiologists from Catalonia (representing Southern Europe), Denmark (representing Scandinavia), Hungary (representing Eastern Europe), Israel, New Zealand (representing Oceania), Scotland (representing Western Europe), and the United States to an in person symposium (May 31, 2023) with lectures and round-table discussions. Epidemiologists were invited to the symposium based on availability, feasibility, and geographic representation of stage 3 regions. Further, these jurisdictions have advanced much of the known stage 3 epidemiology worldwide. This meeting’s goal was to prepare healthcare systems in stage 3 regions to address the rising burden and changing population demographics of IBD. The objectives of this meeting were to describe the current epidemiology of IBD in stage 3 regions; to explore methodological heterogeneity in studying the epidemiology of IBD; to discuss how to provide accessible, equitable, and quality IBD healthcare in a sustainable manner; and to strategize future steps in the prediction and prevention of disease. Addressing these objectives helps clinicians and researchers prioritize activities that counteract the rising burden of IBD.
You can read the article here